Available
Specifications
Manufacturer: Abbott Japan Co., Ltd
Active ingredient:
Shelf life: It is recommended to check the expiration date on the packaging.
Current price
$84
Place an order
Want to find several options? Our manager will clarify all the details of your order and choose a convenient delivery option
Delivery and self-delivery
Storage conditions
Store at a temperature of 1 to 30°C.
Keep away from direct sunlight and moisture.
Store in the original packaging, removing the patch immediately before use.
Keep out of reach of children.
Hocunalin
Hocunalin is a transdermal therapeutic system (patch) containing rotigotine, designed for the treatment of Parkinson's disease and restless legs syndrome (RLS).
Indications for Use:
- Monotherapy for the treatment of early-stage idiopathic Parkinson's disease.
- Combination therapy with levodopa for late-stage Parkinson's disease.
- Symptomatic treatment of moderate to severe restless legs syndrome.
Contraindications:
- Known hypersensitivity to rotigotine or any other components of the drug.
- Severe hepatic impairment.
Side Effects:
- Local Reactions: Redness, itching, or irritation at the application site.
- Gastrointestinal: Nausea, vomiting.
- Neurological: Dizziness, drowsiness, headache.
- Cardiovascular: Orthostatic hypotension.
Precautions:
Before starting treatment with Hocunalin, consult a healthcare provider to determine the appropriate dosage and assess potential risks. Patients should monitor for skin reactions at the application site and symptoms of hypotension, particularly when standing. Regular liver function tests may be recommended for those at risk of hepatic complications.
Transdermal patch (transdermal therapeutic system) with a dosage of 2 mg tulobuterol in each patch.
